Erratum: Increase in prostate cancer distant metastases at diagnosis in the United States (JAMA (2016) DOI: 10.1001/jamaoncol.2016.5465);Increase in prostate cancer distant metastases at diagnosis in the United States

JAMA Oncology

Volumn 3, Issue 5, 2017, Pages 705-707

  Hu, Jim C ^a   Nguyen, Paul ^b   Mao, Jialin ^c   Halpern, Joshua ^a   Shoag, Jonathan ^a   Wright, Jason D ^d   Sedrakyan, Art ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d Columbia College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN; PROSTATE SPECIFIC ANTIGEN;

AGED; BLOOD; CANCER REGISTRY; HUMAN; MALE; PATHOLOGY; PROSTATE TUMOR; UNITED STATES;

AGED; HUMANS; KALLIKREINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 85014829675     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2017.0054     Document Type: Erratum

References (6)

1. National Cancer Institute. Surveillance, Epidemiology, and End Results program. http://seer.cancer.gov/. Accessed April 26, 2016.
2. Schröder FH, Hugosson J, Roobol MJ, et al; ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360(13):1320-1328.
3. Moyer VA; U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157(2):120-134.
4. Shoag JE, Mittal S, Hu JC. Reevaluating PSA testing rates in the PLCO Trial. N Engl J Med. 2016;374(18):1795-1796.
5. Jemal A, Ma J, Siegel R, Fedewa S, Brawley O, Ward EM. Prostate cancer incidence rates 2 years after the US Preventive Services Task Force recommendations against screening [published online August 18, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.2667
6. National Cancer Institute. SEER training modules: what is collaborative stage (CS)? http://training.seer.cancer.gov/collaborative/intro/. Accessed July 30, 2016.